A new survey suggests most Manitobans are against drug-impaired driving.

Eight in 10 people said driving after consuming cannabis was “unacceptable” in a Manitoba Public Insurance survey of 1,500 Manitobans.

The survey comes on the heels of MPI’s newest public awareness campaign to curb drug impaired driving.

“The legalization of non-medical marijuana has changed the landscape of road safety,” said Satvir Jatana, vice-president responsible for Communications, MPI, in a news release. “Medical studies and research from leading organizations have reported marijuana use compromises reaction time and the ability to make safe decisions on the road.”

A third consecutive quarter of EBITDA-positive quarterly results underlines why 48North Cannabis Corp (OTCMKTS: NCNNF) deserves a higher valuation. The stock has been on an impressive run, since the start of the year, despite coming under pressure in recent weeks.

NCNNF catalysts and price analysis

In addition to delivering impressive financial results, the Company has continued to strengthen its long-term prospects, having embarked on an aggressive expansion drive. The Company is in the process of opening one of the world’s largest licensed outdoor cannabis operations a development that continues to excite investors

The Canadian Institutes of Health Research (CIHR) recently announced that it would be pledging nearly $24.5 million to support marijuana research in the country. Reportedly, the funds will help support twenty-six projects throughout Canada “that cover topics such as the use of cannabis and cannabidiol (CBD) oil for the treatment of anxiety and pain.”

Furthermore, the CIHR said that the funding “will also support research teams that will explore the therapeutic potential of marijuana in areas such as chronic pain, cancer and neurodevelopment.”

The two primary reasons for Canada’s investment in cannabis research are:

Tilray (TLRY), a cannabis producer in Canada, was 2018's best-performing stock, thanks to a stratospheric run in September of that year amid a stampede into marijuana stocks. More recently, Tilray stock got a bump in early May after its quarterly sales beat estimates. But is Tilray stock a buy right now?

When legal cannabis debuted in Canada last year, some users were shocked by the amount of packaging required to deliver mere grams of Kush. Naturally, where this packaging ends up after being delivered—be that to a retail location, provincial retailer or customer—became a bit of a head-scratcher for many people.

For better or worse, marijuana is the most popular investment opportunity right now, with the industry slated to see sales grow between fourfold and sixfold by 2030. Among the dozens upon dozens of pot stocks for investors to choose from, it's Aurora Cannabis(NYSE: ACB) that clocks in as the favorite.

But London’s three bricks-and-mortar marijuana stores — all of them open seven days a week — say they have ample supply and don’t plan to decrease operating hours.

The Hobo Recreational Cannabis Store in Ottawa and Canna Cabana in Hamilton are cutting back their hours — closing one day of the week and reducing hours on others — in response to lack of supply.

“It wouldn’t surprise me if the other stores started doing the same thing,” said Michael Armstrong, a professor at Brock University’s Goodman School of Business who studies Canada’s cannabis industry.

Although it's still very early in the legalization process, marijuana offers the potential of being a once-in-a-lifetime growth opportunity. After racking up only $5.4 billion in global legal sales in 2015, Cowen Group analyst Vivien Azer foresees $75 billion in worldwide sales pot sales by 2030. If accurate, this would equate to a compound annual growth rate of better than 19%.

It’s no secret cannabis can be used as a treatment for a number of psychical and psychological conditions. The plant has been used for thousands of years throughout various cultures to manage ailments like joint pain, muscle inflammation, and insomnia. It’s hardly a surprise, then, that a number of athletes have turned to weed for post-game and -training relief.

As perceptions shift, research spikes, and legalization gains traction throughout a number of regions across North America, several professional athletic associations are also changing their tune. Where once a number of these regulatory organizations relegated weed to the "banned substances" list, now they are investing in cannabis research for player wellness.

In case you haven't been paying attention, the marijuana industry has been the buzz on Wall Street for more than two years, and for very good reason. With Canada lifting the curtain on nine decades of recreational prohibition, and more than 40 countries worldwide waving the green flag on medical cannabis, the red carpet is being rolled out for the legal cannabis movement. The massive marijuana industry that's existed in the black market for decades is steadily moving into the legal landscape, providing an opportunity for investors to make bank.